BERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is ...

(MENAFN- GlobeNewsWire - Nasdaq) BERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing ...

Presentation to feature complete safety and immunogenicity dataset from the Phase 1 clinical study of VBI-1501 Oral presentation at IDWeek 2018 on Saturday, October 6 th, 2018, at 11:10 AM PDT ...

In anticipation of IDWeek every year, each of the four sponsoring societies selects one abstract as its top submission from international investigators. Drs. Atukunda and Boulware will present the ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — David J. Weber, MD, MPH, weighed in on findings from the Society of Healthcare Epidemiology of ...

Please provide your email address to receive an email when new articles are posted on . An investigational therapy that uses the gut microbiome was safe and effective in treating recurrent ...

SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Napo Pharmaceuticals, the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) today announced that an abstract associated with an ...